Suppr超能文献

耐多药肺炎链球菌:许多抗生素终结的开端?澳大利亚抗菌药物耐药性小组(AGAR)。

Drug-resistant Streptococcus pneumoniae: the beginning of the end for many antibiotics? Australian Group on Antimicrobial Resistance (AGAR).

作者信息

Collignon P J, Bell J M

机构信息

Infectious Diseases Unit, Woden Valley Hospital, Canberra, ACT.

出版信息

Med J Aust. 1996 Jan 15;164(2):64-7.

PMID:8569573
Abstract

OBJECTIVE

To determine the levels of antibiotic resistance in Streptococcus pneumoniae in Australia.

DESIGN

Prospective, Australia-wide, laboratory-based survey.

SETTING

27 hospital and private laboratories around Australia, from January 1994 to August 1995.

SUBJECTS

First 100 patients with clinically significant isolates of S. pneumoniae at each laboratory.

OUTCOME MEASURES

Resistance to penicillin (determined from penicillin minimum inhibitory concentration [MIC] measured by the Etest), erythromycin, trimethoprim-sulfamethoxazole, tetracycline, chloramphenicol, cefotaxime and ceftriaxone.

RESULTS

A total of 2396 isolates were tested (including 537 invasive isolates and 740 from children). Penicillin resistance was seen in 161 isolates (6.7%), including 17 with high level resistance. Penicillin resistance rates were significantly lower in invasive than in non-invasive strains (3.7% versus 7.6%; odds ratio [OR], 0.47; 95% confidence interval [CI], 0.28-0.77; P = 0.001). There was no significant difference in penicillin resistance rates between children (< 15 years) and adults (7.3% versus 6.5%; OR, 1.14; 95% CI, 0.80-1.63; P = 0.47). Resistance rates were higher for most other antibiotics than for penicillin (chloramphenicol, 6%; erythromycin, 11%; tetracycline, 15%; and trimethoprim-sulfamethoxazole, 42%). No high level resistance was seen to third generation cephalosporins, but 17 of 109 penicillin-resistant isolates tested (16%) displayed intermediate resistance to cefotaxime. Rates of antibiotic resistance varied between States, with the lowest rates in Tasmania.

CONCLUSIONS

Antibiotic resistance levels in S. pneumoniae are increasing in Australia and high level penicillin resistance is being encountered for the first time (including in invasive strains). This will lead to an increasing number of therapeutic dilemmas and possible therapeutic failures, especially important in meningitis.

摘要

目的

确定澳大利亚肺炎链球菌的抗生素耐药水平。

设计

基于实验室的全澳大利亚前瞻性调查。

地点

1994年1月至1995年8月期间澳大利亚各地的27家医院和私立实验室。

研究对象

每家实验室最初的100例有临床意义的肺炎链球菌分离株患者。

观察指标

对青霉素(通过Etest测定青霉素最低抑菌浓度[MIC]来确定)、红霉素、甲氧苄啶-磺胺甲恶唑、四环素、氯霉素、头孢噻肟和头孢曲松的耐药性。

结果

共检测了2396株分离株(包括537株侵袭性分离株和740株儿童分离株)。161株(6.7%)出现青霉素耐药,其中17株为高水平耐药。侵袭性菌株的青霉素耐药率显著低于非侵袭性菌株(3.7%对7.6%;优势比[OR],0.47;95%置信区间[CI],0.28 - 0.77;P = 0.001)。儿童(<15岁)和成人的青霉素耐药率无显著差异(7.3%对6.5%;OR,1.14;95% CI,0.80 - 1.63;P = 0.47)。大多数其他抗生素的耐药率高于青霉素(氯霉素,6%;红霉素,11%;四环素,15%;甲氧苄啶-磺胺甲恶唑,42%)。对第三代头孢菌素未观察到高水平耐药,但在109株检测的青霉素耐药分离株中有17株(16%)对头孢噻肟表现出中介耐药。各州的抗生素耐药率有所不同,塔斯马尼亚州的耐药率最低。

结论

澳大利亚肺炎链球菌的抗生素耐药水平正在上升,首次出现了高水平青霉素耐药(包括侵袭性菌株)。这将导致越来越多的治疗困境和可能的治疗失败,在脑膜炎中尤为重要。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验